Levocetirizine Krka

Levocetirizine, the active ingredient in Levocetirizine Krka, is a H1 receptor antagonist presented as an oral tablet for oral use. It is employed to relieve symptoms of allergic rhinitis and chronic idiopathic urticaria in adults and children. The medication works by selectively blocking peripheral H1 histamine receptors, thereby reducing the release of inflammatory mediators that cause itching, sneezing, and nasal congestion.

GNH USA supplies Levocetirizine Krka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company ensures product quality through rigorous testing and adheres to global regulatory standards.

Levocetirizine, a selective H1 receptor antagonist, is indicated for several IgE‑mediated allergic disorders, helping to control symptoms by inhibiting histamine activity.

Allergic rhinitis: reduces sneezing, itching, and nasal discharge. Seasonal allergic rhinitis: provides symptom relief during pollen exposure. Perennial allergic rhinitis: controls year‑round nasal symptoms. Chronic idiopathic urticaria: diminishes hives and associated itching. Allergic conjunctivitis: alleviates eye itching and redness. Allergic asthma: assists in reducing bronchial hyper‑responsiveness. Contact dermatitis: mitigates itching and rash from allergen exposure.

Levocetirizine may cause adverse reactions, which are categorized by frequency.

Common Side Effects: - Drowsiness: mild sedation or sleepiness. - Dry mouth: reduced salivation. - Headache: transient cranial discomfort. - Nausea: mild gastrointestinal upset.

Serious or Rare Side Effects: - Angioedema: swelling of face, lips, or throat. - Severe rash: including Stevens‑Johnson syndrome. - Anaphylaxis: life‑threatening allergic reaction.

Before initiating Levocetirizine therapy, consider the following precautions.

- Pregnancy: consult a healthcare professional before use. - Breastfeeding: weigh potential benefits against possible infant exposure. - Renal impairment: dose adjustment may be required in reduced kidney function. - Elderly patients: monitor for increased sedation or dizziness. - Concomitant CNS depressants: avoid additive drowsiness. - Store at room temperature: keep in original packaging, protect from moisture and light.

Levocetirizine can interact with other medicines; awareness of major and moderate interactions helps ensure safety and optimal therapeutic outcomes.

Major Interactions (Avoid): - Alcohol: may intensify sedation and impair coordination. - Central nervous system depressants (e.g., benzodiazepines): additive drowsiness risk. - Monoamine oxidase inhibitors: may increase antihistaminic effects.

Moderate Interactions (Monitor Closely): - Ketoconazole or other strong CYP3A4 inhibitors: may increase levocetirizine plasma levels. - Ritonavir: potential elevation of drug concentration. - Theophylline: may enhance side‑effect profile. - Anticholinergic agents: may worsen dry mouth. - Antihypertensive agents: may cause mild hypotension when combined with sedatives.